There are no ongoing discussions regarding an acquisition, nor any indications that the 2021 conversations will be rekindled.
In light of regulatory hurdles, sources told Bloomberg that little market overlap makes the two companies a match to face limited resistance. However, Cigna likely would need to scale back its portfolio to close the deal.
Should acquisition talks resume, it could be the largest deal in the industry. The only two deals of similar scale would be Anthem’s attempted $48 billion purchase of Cigna and Aetna’s proposed $35 billion deal to buy Humana — both of which were blocked by antitrust regulators, according to Bloomberg.
The acquisition would give Cigna more access to government-sponsored markets, in which Centene is highly competitive.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
